Position in PTCT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$128,550,475
+$19,809,409 QoQ
Shares Held
1,886,841
+31.8% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 72.981030198093.ToString("F0")%
Shared 0.ToString("F0")%
None 27.018969801906994.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. PTCT ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $128,550,475 | 1,886,841 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $108,741,066 | 1,431,557 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $93,100,496 | 1,517,036 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $67,467,965 | 1,381,408 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,301,830 | 516,127 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,580,031 | 256,536 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,676,220 | 314,723 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,506,187 | 310,863 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,161,744 | 383,697 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,329,276 | 265,939 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,497,152 | 379,168 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,597,939 | 457,289 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,621,869 | 446,364 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,505,361 | 380,020 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $17,046,059 | 339,563 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,312,513 | 357,277 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,663,008 | 285,795 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $104,917,913 | 2,634,143 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $10,494,593 | 282,037 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,158,666 | 287,643 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $17,174,315 | 362,710 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,648,215 | 338,329 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $18,643,243 | 398,786 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,655,704 | 269,131 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,538,217 | 236,230 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||